Showing results (161-170 of 294) with videos related to
Sort By:
Pageof 30
Anticancer Research|July 1, 1997
Anti-p53 autoantibodies in hepatitis C virus-infected patientsJ Raedle, G Oremek, W K Roth, et al.Digestive Diseases and Sciences|December 1, 1995
Alpha-fetoprotein and p53 autoantibodies in patients with chronic hepatitis CJ Raedle, W K Roth, G Oremek, et al.Zeitschrift Fur Gastroenterologie|July 19, 2016
[Expert recommendations: Hepatitis C and transplantation]T Zimmermann, S Beckebaum, C Berg, et al.Journal of Medical Virology|January 12, 2000
Antiviral effect of human recombinant interleukin-12 in patients infected with hepatitis C virusJ H Lee, G Teuber, M von Wagner, et al.Zeitschrift Fur Gastroenterologie|December 26, 2001
[Hypertransaminasaemia and impaired liver function in a patient with oligosymptomatic celiac disease]W P Hofmann, C F Dietrich, W Holtmeier, et al.Deutsche Medizinische Wochenschrift (1946)|February 28, 2001
[Retrospective cohort study of lamivudine therapy in patients with chronic hepatitis B]G Teuber, H F Löhr, B Kallinowski, et al.Clinical Chemistry|February 1, 1996
Immunoreactive elastase I: clinical evaluation of a new noninvasive test of pancreatic functionJ Stein, M Jung, A Sziegoleit, et al.Proceedings of the National Academy of Sciences of the United States of America|July 15, 1992
Intravesicular acidification correlates with binding of ADP-ribosylation factor to microsomal membranesS Zeuzem, P Feick, P Zimmermann, et al.Journal of Viral Hepatitis|July 18, 2006
The economics of treating chronic hepatitis C patients with peginterferon alpha-2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferaseJ Hornberger, P Farci, D Prati, et al.Hepatology (Baltimore, Md.)|February 1, 1996
Effect of interferon alfa on the dynamics of hepatitis C virus turnover in vivoS Zeuzem, J M Schmidt, J H Lee, et al.Pageof 30